Granules India Limited has disclosed a significant change in its promoter and promoter group’s shareholding. Following a sale of 1,72,00,000 equity shares on September 11, 2026, the aggregate shareholding of the promoter group has decreased from 38.02% to 31.08%. The transaction involved institutional investors and was undertaken to fund the company’s ongoing preferential issue and growth initiatives.
Promoter Group Sells Significant Stake
Granules India Limited has announced a substantial change in its ownership structure. The company has received intimation from its promoter, Dr. Krishna Prasad Chigurupati, regarding the sale of 1,72,00,000 equity shares of the company on September 11, 2026. The transaction was executed through a block deal and the open market.
Institutional Investor Participation and Funding Rationale
The sale saw participation from several marquee institutional investors, including Capital Group, Kotak Mahindra Life Insurance Company, ChrysCapital, and Allspring, alongside other domestic and global investors. The primary purpose of this transaction was to facilitate the funding for the second tranche of the company’s ongoing preferential issue and to support the next phase of its growth initiatives, aligning with the company’s stated objectives.
Impact on Shareholding
Following this transaction, the aggregate shareholding of the Promoter and Promoter Group in Granules India Limited has altered. The shareholding has decreased from 38.02% to 31.08% of the company’s paid-up equity share capital. On a diluted basis, the aggregate shareholding of the Promoter and Promoter Group now stands at 37.39%. Furthermore, Dr. Krishna Prasad Chigurupati’s individual shareholding as a promoter has reduced from 31.00% to 24.06% of the paid-up equity share capital.
Strategic Growth Initiatives
The company highlighted that the funds raised through the preferential issue in February 2026 have been deployed to execute identified growth initiatives. These initiatives are progressing at a pace faster than initially anticipated, reflecting the company’s focused execution. The utilization of funds remains fully aligned with the objects disclosed at the time of the preferential issue.
Source: BSE
